[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fDWqOH4BfXftxaPjG0mTkUVdq8ab8xo995Fo1e_0ib98":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":53,"rows":60},"Centre Hospitalier Universitaire de la Réunion",[4],135,false,36,5,1774963,4,120,[14,16,18,21,23,25,27,30],{"name":15,"count":9},"Diabetes",{"name":17,"count":11},"Lipodystrophy",{"name":19,"count":20},"Chikungunya Virus Infection",3,{"name":22,"count":20},"Obesity",{"name":24,"count":20},"Sport Injury",{"name":26,"count":20},"Leptospirosis",{"name":28,"count":29},"Chikungunya Fever",2,{"name":31,"count":29},"Cardiovascular Disease",[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT05898009","Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2","2025-03-22","blood sample for BRCA2 mutation detection",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06928753","Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Réunion","2026-04","IXCHIQ",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT07190560","Against Chikungunya Virus and Neonatal Infection","2027-10-01","plasma transfusion : PC-CHIK-V",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT07119086","Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean","2037-05-05","Biological samples",[54,55,56,57,58,59],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[61,85,109,133,154,181,209,227,245,270,294,323,341,366,384,409,436,463,487],{"intervention":42,"totalTrials":62,"cells":63},1,{"EARLY_PHASE1":64,"PHASE1":67,"PHASE2":69,"PHASE3":71,"PHASE4":73,"NA":83},{"trials":65,"activeCount":66},[],0,{"trials":68,"activeCount":66},[],{"trials":70,"activeCount":66},[],{"trials":72,"activeCount":66},[],{"trials":74,"activeCount":62,"soonestReadout":41},[75],{"nctId":39,"briefTitle":40,"status":76,"phases":77,"primaryCompletion":41,"completion":78,"start":79,"enrollment":80,"conditions":81,"interventions":82},"RECRUITING",[58],"2026-10","2025-04-18",1800,[19],[42],{"trials":84,"activeCount":66},[],{"intervention":37,"totalTrials":62,"cells":86},{"EARLY_PHASE1":87,"PHASE1":89,"PHASE2":91,"PHASE3":93,"PHASE4":95,"NA":97},{"trials":88,"activeCount":66},[],{"trials":90,"activeCount":66},[],{"trials":92,"activeCount":66},[],{"trials":94,"activeCount":66},[],{"trials":96,"activeCount":66},[],{"trials":98,"activeCount":62,"soonestReadout":36},[99],{"nctId":34,"briefTitle":35,"status":76,"phases":100,"primaryCompletion":36,"completion":101,"start":102,"enrollment":103,"conditions":104,"interventions":108},[59],"2026-03-22","2023-10-19",300,[105,106,107],"Breast Cancer","Genetic Disease","BRCA2 Mutation",[37],{"intervention":47,"totalTrials":62,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":117,"PHASE4":119,"NA":121},{"trials":112,"activeCount":66},[],{"trials":114,"activeCount":66},[],{"trials":116,"activeCount":66},[],{"trials":118,"activeCount":66},[],{"trials":120,"activeCount":66},[],{"trials":122,"activeCount":62,"soonestReadout":46},[123],{"nctId":44,"briefTitle":45,"status":76,"phases":124,"primaryCompletion":46,"completion":125,"start":126,"enrollment":127,"conditions":128,"interventions":132},[59],"2027-12-01","2026-08-01",60,[19,129,130,131],"Neonatal","Transfusion","Encephalopathy",[47],{"intervention":52,"totalTrials":62,"cells":134},{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":141,"PHASE4":143,"NA":145},{"trials":136,"activeCount":66},[],{"trials":138,"activeCount":66},[],{"trials":140,"activeCount":66},[],{"trials":142,"activeCount":66},[],{"trials":144,"activeCount":66},[],{"trials":146,"activeCount":62,"soonestReadout":51},[147],{"nctId":49,"briefTitle":50,"status":76,"phases":148,"primaryCompletion":51,"completion":51,"start":149,"enrollment":150,"conditions":151,"interventions":153},[59],"2025-06-02",200,[152],"Arbovirus Disease",[52],{"intervention":155,"totalTrials":62,"cells":156},"Gardasil 9, 9-Valent Intramuscular Suspension",{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":179},{"trials":158,"activeCount":66},[],{"trials":160,"activeCount":66},[],{"trials":162,"activeCount":66},[],{"trials":164,"activeCount":66},[],{"trials":166,"activeCount":66},[167],{"nctId":168,"briefTitle":169,"status":170,"phases":171,"primaryCompletion":172,"completion":173,"start":174,"enrollment":175,"conditions":176,"interventions":178},"NCT04459221","Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School Students","COMPLETED",[58],"2021-06-25","2021-12-30","2020-11-01",355,[177],"Papilloma Viral Infection",[155],{"trials":180,"activeCount":66},[],{"intervention":182,"totalTrials":62,"cells":183},"Dexamethasone",{"EARLY_PHASE1":184,"PHASE1":186,"PHASE2":188,"PHASE3":190,"PHASE4":205,"NA":207},{"trials":185,"activeCount":66},[],{"trials":187,"activeCount":66},[],{"trials":189,"activeCount":66},[],{"trials":191,"activeCount":66},[192],{"nctId":193,"briefTitle":194,"status":195,"phases":196,"primaryCompletion":197,"completion":197,"start":198,"enrollment":66,"conditions":199,"interventions":202},"NCT02857465","Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome","WITHDRAWN",[57],"2017-06","2017-01",[200,201],"Obstetric Pain","Other Complications of Obstetric Anesthesia - Delivered",[182,203,204],"Ropivacaine","Sufentanil",{"trials":206,"activeCount":66},[],{"trials":208,"activeCount":66},[],{"intervention":203,"totalTrials":62,"cells":210},{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":223,"NA":225},{"trials":212,"activeCount":66},[],{"trials":214,"activeCount":66},[],{"trials":216,"activeCount":66},[],{"trials":218,"activeCount":66},[219],{"nctId":193,"briefTitle":194,"status":195,"phases":220,"primaryCompletion":197,"completion":197,"start":198,"enrollment":66,"conditions":221,"interventions":222},[57],[200,201],[182,203,204],{"trials":224,"activeCount":66},[],{"trials":226,"activeCount":66},[],{"intervention":204,"totalTrials":62,"cells":228},{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":235,"PHASE4":241,"NA":243},{"trials":230,"activeCount":66},[],{"trials":232,"activeCount":66},[],{"trials":234,"activeCount":66},[],{"trials":236,"activeCount":66},[237],{"nctId":193,"briefTitle":194,"status":195,"phases":238,"primaryCompletion":197,"completion":197,"start":198,"enrollment":66,"conditions":239,"interventions":240},[57],[200,201],[182,203,204],{"trials":242,"activeCount":66},[],{"trials":244,"activeCount":66},[],{"intervention":246,"totalTrials":62,"cells":247},"Minidril®\u002FLeeloo®",{"EARLY_PHASE1":248,"PHASE1":250,"PHASE2":252,"PHASE3":254,"PHASE4":266,"NA":268},{"trials":249,"activeCount":66},[],{"trials":251,"activeCount":66},[],{"trials":253,"activeCount":66},[],{"trials":255,"activeCount":66},[256],{"nctId":257,"briefTitle":258,"status":259,"phases":260,"primaryCompletion":261,"completion":261,"start":262,"enrollment":29,"conditions":263,"interventions":265},"NCT02669238","Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis","TERMINATED",[56,57],"2019-10-10","2018-05-25",[264],"Endometriosis",[246],{"trials":267,"activeCount":66},[],{"trials":269,"activeCount":66},[],{"intervention":271,"totalTrials":62,"cells":272},"PET scanner with injection of 18 FDG",{"EARLY_PHASE1":273,"PHASE1":275,"PHASE2":277,"PHASE3":279,"PHASE4":290,"NA":292},{"trials":274,"activeCount":66},[],{"trials":276,"activeCount":66},[],{"trials":278,"activeCount":66},[],{"trials":280,"activeCount":66},[281],{"nctId":282,"briefTitle":283,"status":170,"phases":284,"primaryCompletion":285,"completion":285,"start":286,"enrollment":287,"conditions":288,"interventions":289},"NCT04831619","Contribution of PET (Positron Emission Tomography) Scans for the Preoperative Assessment of Symptomatic Endometriosis Lesions: TEP-ENDORUN",[57],"2025-04-24","2023-12-12",15,[264],[271],{"trials":291,"activeCount":66},[],{"trials":293,"activeCount":66},[],{"intervention":295,"totalTrials":62,"cells":296},"Succinylcholine : 1mg\u002Fkg",{"EARLY_PHASE1":297,"PHASE1":299,"PHASE2":301,"PHASE3":303,"PHASE4":319,"NA":321},{"trials":298,"activeCount":66},[],{"trials":300,"activeCount":66},[],{"trials":302,"activeCount":66},[],{"trials":304,"activeCount":66},[305],{"nctId":306,"briefTitle":307,"status":170,"phases":308,"primaryCompletion":309,"completion":309,"start":310,"enrollment":311,"conditions":312,"interventions":317},"NCT02000674","Succinylcholine vs Rocuronium for Prehospital Emergency Intubation",[57],"2016-07","2013-12",1321,[313,314,315,316],"Coma","Major Trauma","Respiratory Distress","Shock",[295,318],"Rocuronium : 1.2 mg\u002Fkg",{"trials":320,"activeCount":66},[],{"trials":322,"activeCount":66},[],{"intervention":318,"totalTrials":62,"cells":324},{"EARLY_PHASE1":325,"PHASE1":327,"PHASE2":329,"PHASE3":331,"PHASE4":337,"NA":339},{"trials":326,"activeCount":66},[],{"trials":328,"activeCount":66},[],{"trials":330,"activeCount":66},[],{"trials":332,"activeCount":66},[333],{"nctId":306,"briefTitle":307,"status":170,"phases":334,"primaryCompletion":309,"completion":309,"start":310,"enrollment":311,"conditions":335,"interventions":336},[57],[313,314,315,316],[295,318],{"trials":338,"activeCount":66},[],{"trials":340,"activeCount":66},[],{"intervention":342,"totalTrials":62,"cells":343},"Saliva collection",{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":350,"PHASE4":352,"NA":354},{"trials":345,"activeCount":66},[],{"trials":347,"activeCount":66},[],{"trials":349,"activeCount":66},[],{"trials":351,"activeCount":66},[],{"trials":353,"activeCount":66},[],{"trials":355,"activeCount":66},[356],{"nctId":357,"briefTitle":358,"status":170,"phases":359,"primaryCompletion":360,"completion":360,"start":361,"enrollment":362,"conditions":363,"interventions":364},"NCT03690648","Genetic Factors and Immunological Determinism of Persistent Consequences of Chikungunya",[],"2021-12-31","2018-08-01",600,[28],[342,365],"Blood collection",{"intervention":365,"totalTrials":62,"cells":367},{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":378},{"trials":369,"activeCount":66},[],{"trials":371,"activeCount":66},[],{"trials":373,"activeCount":66},[],{"trials":375,"activeCount":66},[],{"trials":377,"activeCount":66},[],{"trials":379,"activeCount":66},[380],{"nctId":357,"briefTitle":358,"status":170,"phases":381,"primaryCompletion":360,"completion":360,"start":361,"enrollment":362,"conditions":382,"interventions":383},[],[28],[342,365],{"intervention":385,"totalTrials":62,"cells":386},"Biological Collection",{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":393,"PHASE4":395,"NA":397},{"trials":388,"activeCount":66},[],{"trials":390,"activeCount":66},[],{"trials":392,"activeCount":66},[],{"trials":394,"activeCount":66},[],{"trials":396,"activeCount":66},[],{"trials":398,"activeCount":66},[399],{"nctId":400,"briefTitle":401,"status":170,"phases":402,"primaryCompletion":403,"completion":403,"start":404,"enrollment":405,"conditions":406,"interventions":408},"NCT05598138","Clinical and Biological Strokes Collection in Reunion Island",[59],"2023-06-21","2021-06-22",795,[407],"Stroke",[385],{"intervention":410,"totalTrials":62,"cells":411},"Bood and urine sampling",{"EARLY_PHASE1":412,"PHASE1":414,"PHASE2":416,"PHASE3":418,"PHASE4":420,"NA":422},{"trials":413,"activeCount":66},[],{"trials":415,"activeCount":66},[],{"trials":417,"activeCount":66},[],{"trials":419,"activeCount":66},[],{"trials":421,"activeCount":66},[],{"trials":423,"activeCount":66},[424],{"nctId":425,"briefTitle":426,"status":427,"phases":428,"primaryCompletion":429,"completion":430,"start":431,"enrollment":432,"conditions":433,"interventions":435},"NCT06107439","Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects","UNKNOWN",[59],"2024-08-13","2025-08-13","2023-08-14",80,[17,434],"Dunnigan Syndrome",[410],{"intervention":437,"totalTrials":62,"cells":438},"Dabigatran",{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":445,"PHASE4":447,"NA":449},{"trials":440,"activeCount":66},[],{"trials":442,"activeCount":66},[],{"trials":444,"activeCount":66},[],{"trials":446,"activeCount":66},[],{"trials":448,"activeCount":66},[],{"trials":450,"activeCount":66},[451],{"nctId":452,"briefTitle":453,"status":170,"phases":454,"primaryCompletion":455,"completion":456,"start":310,"enrollment":457,"conditions":458,"interventions":462},"NCT02904499","Use of Public Health Surveillance Models in the French National Health System Database",[],"2016-09","2018-07",814446,[459,460,461],"Atrial Fibrillation","Anticoagulants","Pharmacoepidemiology",[437],{"intervention":464,"totalTrials":62,"cells":465},"EGFR mutation",{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":474,"NA":476},{"trials":467,"activeCount":66},[],{"trials":469,"activeCount":66},[],{"trials":471,"activeCount":66},[],{"trials":473,"activeCount":66},[],{"trials":475,"activeCount":66},[],{"trials":477,"activeCount":66},[478],{"nctId":479,"briefTitle":480,"status":170,"phases":481,"primaryCompletion":482,"completion":482,"start":483,"enrollment":127,"conditions":484,"interventions":486},"NCT04261725","Prevalence of EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion Island",[],"2022-01-18","2020-02-24",[485],"Squamous Cell Lung Cancer",[464],{"intervention":488,"totalTrials":62,"cells":489},"Blood sample",{"EARLY_PHASE1":490,"PHASE1":492,"PHASE2":494,"PHASE3":496,"PHASE4":498,"NA":500},{"trials":491,"activeCount":66},[],{"trials":493,"activeCount":66},[],{"trials":495,"activeCount":66},[],{"trials":497,"activeCount":66},[],{"trials":499,"activeCount":66},[],{"trials":501,"activeCount":66},[502],{"nctId":503,"briefTitle":504,"status":170,"phases":505,"primaryCompletion":506,"completion":506,"start":507,"enrollment":508,"conditions":509,"interventions":511},"NCT06585930","Relation Between the Value of Platelet Clot Stiffness (PCS) Obtained by Sonorheometric Method of Delocalized Hemostasis (QUANTRA®), and the Presence of a Disorder of Primary Hemostasis, in Cardiac Surgery Patients. PLAQUA-Study",[],"2025-04-04","2024-08-30",100,[510],"Primary Haemostasis Disorder in Cardiac Surgery Patients",[488]]